MDMA
Vox: Psychedelics are outperforming trauma researchers’ expectations. But why?
The stakes were high: This was the final phase — phase 3 — of MAPS’s study aiming to convince the FDA to approve MDMA-assisted therapy for PTSD. Doblin knew that if the participants didn’t see …
Psychedelic Alpha: MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics
Today’s announcement perhaps reflects something of an eggshell-treading transition: Lykos has dropped “MAPS” from its name, but perhaps retains a nod to its founder and its nonconformist roots; it’s …
Forbes: MAPS Applies For FDA Approval Of MDMA-Assisted Therapy For PTSD
“As cannabis, MDMA, psilocybin, and other drugs inch closer to potential FDA approval as safe and effective treatments, yet another harm of the War on Drugs is revealed: decades of missed opportunity …
MAPS Celebrates Submission of New Drug Application to FDA for MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: December 13, 2023 MAPS Public Benefit Corporation (MAPS PBC) formally submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) which included data from …
MAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: September 14, 2023 Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder, MAPP2, have been published in Nature Medicine. MAPP2 …
ECOA: Lieutenant uses psychedelics to combat police violence in the US.
It was at an IACP conference in Florida, the largest event for police officers in the world, that Gergerian met Rick Doblin, the former hippie and founder of Maps (an acronym in English for “Multidisciplinary …
Microdose: An Introduction to MDMA Therapy
MDMA has been gaining attention for its potential therapeutic applications. In recent years, MDMA therapy, particularly MDMA-assisted psychotherapy, has been a topic of extensive research, with MAPS’ …
Mugglehead Magazine: American Medical Association approves medical code for psychedelic therapies coverage
The code was the result of a partnership between U.K.-based COMPASS Pathways and the Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation to facilitate access and insurance …
Nature: US could soon approve MDMA therapy — opening an era of psychedelic medicine
Quote Originally appearing here (Archived)
STATEMENT: MAPS-Funded Phase 3 Research Reports Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: April 5, 2023 MAPS Public Benefit Corporation (MAPS PBC), a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), announced preliminary findings …
Greenmarket Report: Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs
The bill – HD 2137, by state Rep. Nicholas Boldyga – was introduced in January, apparently in response to reporting by The Washington Post and The New York Times regarding moves by the nonprofit …